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A DNA methyltransferase has been identified that plays
a role in maintaining the methylation status of
imprinted genes. Interestingly, although expressed in
the unfertilised egg, this enzyme functions only during
one round of replication in the eight-cell embryo.
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DNA methylation plays a key role in the acquisition of
functional epigenetic modifications to DNA. It is important
for the regulation of X chromosome inactivation and the
silencing of parasitic elements within the genome, and is
associated with genome stability [1,2]. In particular, DNA
methylation is one of the important defining features of
imprinted domains, and the characteristic parent-of-origin
specific expression of imprinted genes is frequently estab-
lished or maintained by the differential methylation of the
two parental alleles [3,4]. In the absence of DNA methyla-
tion, mammalian embryonic development does not proceed
past midgestation [5].
Several DNA methyltransferases have now been identified
and much effort is being put into determining the differ-
ent roles these enzymes play in establishing new methyla-
tion patterns and maintaining existing ones. A recent study
[6] indicates that one of these enzymes, Dnmt1o, exhibits
a remarkable temporal specificity for the maintenance
methylation of imprinted genes during preimplantation
development. This adds a new tier to the methylation
processes that are so critical for some of the earliest pro-
gramming events in the mammalian genome.
Dynamics of DNA methylation and enzymes involved
The process of DNA methylation is a dynamic one during
mammalian development. Before fertilisation, the gamete
chromosomes are relatively methylated, in general those of
sperm being more methylated than those of oocytes. After
fertilisation, there is a loss of methylation from both parental
sets of chromosomes [7–10]. Remarkably, the preimplanta-
tion loss of methylation occurs asymmetrically. That is,
during pronuclear maturation and before any DNA repli-
cation, the paternal genome is rapidly and selectively
demethylated — a process termed ‘active demethylation’
[11,12]. The nature and mechanism of this event is cur-
rently the subject of intense interest and some contro-
versy. In contrast to the paternal genome, the maternally
inherited chromosomes are progressively demethylated
over several rounds of cell division — ‘passive demethyla-
tion’ [7,10], consistent with the absence of DNA methyl-
transferases responsible for replication-mediated ‘main-
tenance’ methylation. After implantation, there is a wave
of de novo methylation and subsequent maintenance
methylation restores methylation profiles to the levels
usually described for somatic cells [13]. 
To date, three functional DNA methyltransferases have
been identified in the mouse: Dnmt1, Dnmt3A and
Dnmt3B (reviewed in [1]). Mice which do not express
these genes die by mid-gestation [5,14]. Dnmt3A and
Dnmt3B are de novo methyltransferases which act on
different types of non-methylated DNA template [14].
Dnmt1 is the principle activity responsible for mainte-
nance methylation, owing largely to its strong preference
for hemi-methylated DNA [15]. Interestingly, in biochem-
ical assays, Dnmt1 has a greater de novo methylase activity
than Dnmt3A or Dnmt3B [15].
There are three forms of Dnmt1, and of particular interest
is a shorter germ-cell-specific form, Dnmt1o, which has a
nuclear localisation signal and is found in growing oocytes
and during preimplantation development [16]. As the
growth of the oocyte occurs in the absence of replication,
the suggestion was made that Dnmt1o may have an impor-
tant de novo methylation function in these female germ
cells [16]. After fertilisation, this extremely abundant form
of Dnmt1 is relegated to the cytoplasm. The protein is
specifically partitioned to the subcortex of individual blas-
tomeres in the earliest stages of preimplantation develop-
ment; it then moves further into the cytoplasm until the
eight-cell stage when, for a single cell cycle, it is observed
to enter the nucleus [16,17]. Dnmt1o is then excluded
from the nucleus in subsequent cell cycles, until post-
implantation day 8 [17]. The consequences of this remark-
able activity in conjunction with the idea of its proposed
function as a de novo methylase marking imprinted genes in
the oocyte is addressed in a recent study by Howell et al. [6].
Consequences of Dnmt1o deficiency
Howell et al. [6] made a mouse strain deficient in Dnmt1o
by deleting the Dnmt1 gene’s oocyte-specific promoter.
The exciting results included in their report are first, that
the Dnmt1o deficiency has no effect on the development
of the oocyte and the establishment of methylation
imprints. This indicates, in contrast to the earlier sugges-
tion [16], that Dnmt1o is not essential for de novo methy-
lase function in the female germline. Second, as expected
for a Dnmt1 isoform expressed in the egg, no effect on
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embryonic development was observed when the mutation
was paternally inherited. Indeed, this is an example of a
classical maternal-effect mutation. Inheritance from a mater-
nal homozygote causes a remarkably broad spectrum of
developmental stages of lethality, extending from embry-
onic day 14 through to postnatal time points. Third, and
perhaps of greatest interest, the authors observed a quan-
tifiable reduction of appropriate methylation maintenance
at imprinted genes in the embryo.
These findings led Howell et al. [6] to suggest that the
transient nuclear localisation of Dnmt1o in eight-cell
embryos provides maintenance methyltransferase activity
specifically at imprinted loci during the fourth embryonic
S phase. This raises the question of why imprinted genes,
considered to be privileged in their exclusion from
genome-wide demethylation, are specifically targeted by
this enzyme at this single stage. The three key issues here
are therefore ones of Dnmt1o function as a maintenance
methylase, target specificity to imprinted genes and the
exquisite timing of this methylase function.
Implications of the findings
Allele-specific methylation was established appropriately
in the mutants, but the absence of maintenance methyla-
tion during one cell division resulted in a 50% loss of
methylation from the usually methylated allele irrespective
of parental origin (Figure 1). This also suggests Dnmt1o is
a maintenance methylase with no de novo function. This is
relevant because, although key methylation imprints are
accepted as being established in the germline and believed
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Schematic representation of the effect of the Dnmt1o deficiency on the
methylation of a paternally methylated allele, shown over two rounds of
replication (for simplicity only one maternal and one paternal strand is
depicted at the eight-cell stage). Maternal methylation imprints behave
in the same way. Newly replicated strands are shown as dotted lines.
Here the paternal allele is shown in blue and the maternal allele in
green. Methylated CpGs are shown as filled circles and unmethylated
CpGs as open circles. In the mutant, allele-specific methylation is
established normally and maintained to the eight-cell stage. At the
eight-cell stage, the absence of Dnmt1o results in failure of the newly
replicated paternal strand to become methylated. Subsequently
maintenance methylation occurs normally, but there is a reduction by
50% of methylation on newly replicated paternal alleles. This heritable
change results in some cells having either differentially methylated
parental alleles or ones that are unmethylated. This ‘epigenetic
mosaicism’ is associated with lethality.
demethylation events, complete allele-specific methyla-
tion data throughout every stage of preimplantation devel-
opment have only been obtained for H19 [18]. Hence
there might be a requirement for an allele-specific de novo
methylase function at preimplantation stages. However,
the data presented clearly do not support such a function
for this enzyme.
Allele-specific methylation must have occurred appropri-
ately in the mutants, because the two parental alleles of
imprinted genes are still differentially methylated. What is
perturbed is the level of methylation on the appropriate
allele. The absence of maintenance methylation over one
cell division results in loss of methylation on the newly
replicated strands of the methylated allele, as illustrated in
Figure 1. Subsequent maintenance methylation activity in
the next cell divisions does not, therefore, recognise these
strands and, as a consequence, a mosaic pattern of cellular
methylation is established. This change in methylation
level, together with the observation that Dnmt1o is
nuclear at the eight-cell stage but cytoplasmic by the 16-
cell stage, indicates that, in the mutant, a single round of
replication has occurred in the absence of a maintenance
methylase. This has profound consequences for the fetus.
This is a truly impressive example of highly regulated
biochemical specificity. 
Because of the apparently exclusive function of Dnmt1o at
the eight-cell stage, the enzyme(s) responsible for mainte-
nance of methylation imprints before and after this stage
remains elusive. Furthermore, what happens to that activity
at the eight-cell stage? Presumably it must have imprint
specificity because it needs to function in a background of
the passive demethylation going on elsewhere in the
genome. Furthermore, it is unlikely to have de novo methy-
lase function because the methylation defects in the
Dnmt1o mutant appear to be heritably maintained. 
So why not have a single activity maintaining the methyla-
tion imprints throughout preimplantation development?
What is special about the eight-cell stage? Perhaps the
answer lies in the changes in totipotency that occur at this
time, when the blastomeres of the embryo exhibit different
cellular features and are known to acquire an ‘inside–outside
identity’, arguably the very first cell determination events.
These changes lead to the formation of presumptive
embryonic (inside) and presumptive extraembryonic
(outside) lineages [19,20]. Methylation differences have
been reported between these two lineages, with the
extraembryonic cells being generally less methylated than
those of the embryo [21,22]. This is consistent with the
finding that correct X inactivation in extraembryonic
tissues does not require DNA methylation, in contrast
with the need for methylation to inactivate the X in
embryonic lineages [23].
It is tempting to speculate that, at the 8–16 cell stage,
there may be variation in the action of the maintenance
event, and that this might contribute to the methylation
differences between the two lineages and perhaps even
to this early differentiation process itself. This might
require a stage-specific enzyme. If this asymmetry of
imprinted gene methylation is perturbed in the mutant, a
consequence might be significant and variable effects on
the growth and development of the embryo, but perhaps
not the placenta. Although no phenotypic details are
presented by Howell et al. [6], the broad spectrum of
lethality stages associated with the Dnmt1o deficiency is
consistent with this idea. Indeed, the authors suggest
that the inappropriate reactivation of imprinted genes
that have segregated randomly could explain the wide-
ranging phenotypic variation. It will be interesting to
determine whether there is any segregation of alleles on
the basis of methylation into embryonic or extraembry-
onic compartments at this critical lineage-determining
eight-cell stage.
Outstanding issues
Not surprisingly, the new work of Howell et al. [6] raises
more questions than it answers. Clearly there must be
another activity responsible for the maintenance of the
methylation imprints during preimplantation stages.
Dnmt3A and Dnmt3B are not good candidates, because of
their in vivo functions as de novo methylases [14]. It is
known that, after implantation, another Dnmt1 isoform
functions as a maintenance methylase acting on imprinted
genes and elsewhere [5], so the search must continue
for candidates responsible for maintenance methylation
during preimplantation.
The remarkable temporal control of Dnmt1o function
suggests a highly regulated process of protein localisation.
Questions concerning the exact identity and regulation of
the molecules responsible for the subcortical distribution
of Dnmt1o, followed by its release and subsequent move-
ment into and out of the nucleus, are equally compelling.
How important is the timing of these events? Can tempo-
ral misregulation alter methylation? And what might be
the consequences of this for imprinting and lineage alloca-
tion? From an evolutionary point of view, why is this
enzyme maternally expressed? Why is there such a varia-
tion in the phenotypic outcome of maternally inherited
Dnmt1o mutant? Elegant cell biology and transgenic
approaches may well provide answers to some of these
questions and continue to impress us with the levels of
epigenetic complexity so precisely regulated at these very
early stages to ensure viable normal offspring. 
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